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ABSTRACT: The potassium eﬄux system, Kef, protects
bacteria against the detrimental eﬀects of electrophilic
compounds via acidiﬁcation of the cytoplasm. Kef is inhibited
by glutathione (GSH) but activated by glutathione-S-
conjugates (GS-X) formed in the presence of electrophiles.
GSH and GS-X bind to overlapping sites on Kef, which are
located in a cytosolic regulatory domain. The central paradox
of this activation mechanism is that GSH is abundant in cells
(at concentrations of ∼10−20 mM), and thus, activating
ligands must possess a high diﬀerential over GSH in their
aﬃnity for Kef. To investigate the structural requirements for
binding of a ligand to Kef, a novel ﬂuorescent reporter ligand,
S-{[5-(dimethylamino)naphthalen-1-yl]sulfonylaminopropyl}
glutathione (DNGSH), was synthesized. By competition assays using DNGSH, complemented by direct binding assays and
thermal shift measurements, we show that the well-characterized Kef activator, N-ethylsuccinimido-S-glutathione, has a 10−20-
fold higher aﬃnity for Kef than GSH. In contrast, another native ligand that is a poor activator, S-lactoylglutathione, exhibits a
similar Kef aﬃnity to GSH. Synthetic ligands were synthesized to contain either rigid or ﬂexible structures and investigated as
ligands for Kef. Compounds with rigid structures and high aﬃnity activated Kef. In contrast, ﬂexible ligands with similar binding
aﬃnities did not activate Kef. These data provide insight into the structural requirements for Kef gating, paving the way for the
development of a screen for potential therapeutic lead compounds targeting the Kef system.
Potassium ion (K+) transport is a major determinant ofbacterial growth and survival through its role in regulating
cytoplasmic pH and cell turgor. The Kef system, which
comprises both KefFC and KefGB (in Escherichia coli), is a
ligand-gated K+ eﬄux system critical for the bacterial response
to electrophilic insult.1,2 The thiol-containing tripeptide
glutathione (GSH) acts as an inhibitory ligand of Kef, holding
the channel closed. However, in the presence of electrophiles,
GSH chemically reacts with these species forming GS-X, which
activates the Kef system resulting in K+ eﬄux and concomitant
H+ inﬂux. Consequently, activation of Kef results in a decrease
in cellular pH, protonating nucleophiles in DNA and proteins
and minimizing their reactivity with electrophilic species.1,2 The
GS-X conjugates subsequently undergo metabolism to less
toxic species in enzyme-mediated detoxiﬁcation reactions that
also regenerate cytoplasmic GSH.3,4 Hence, Kef is part of a
synergistic bacterial protection system, in which the electro-
philes are detoxiﬁed and, in parallel, their eﬀect is neutralized by
modulation of the cellular pH (Figure 1). Previous work has
established that the rate and extent of activation of Kef are
critical determinants in the survival of bacteria after their
exposure to toxic electrophiles.5,6 Therefore, perturbation of
Kef activity is potentially a novel target for antibiotic drugs, but
such compounds can be developed only with a thorough
understanding of Kef activation at the molecular level.
A combination of crystallographic studies and classical
bacterial genetics has provided a mechanistic model by which
GSH and GS-X bind to Kef and modulate its activity. Kef
proteins are homodimeric and possess a carboxy-terminal K+
transport and nucleotide binding (KTN) domain, which
contains a Rossmann fold that binds a nucleotide molecule.7,8
The GSH/GS-X binding site resides at the interface of the two
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KTN domains. A number of key residues bind the peptide
component of both GSH and GS-X and anchor the molecule to
the Kef protein (Figure 2). Three critical residues were
identiﬁed by classical bacterial genetics, R416, R516, and N551
(E. coli KefC numbering).8,9 Mutations at these positions
caused a phenotype equivalent to that seen after the loss of
GSH from the cell and were thus implicated in deﬁning the
GSH binding site.8,9 Crystallography in which apo and ligand
(GS-X)-bound structures were described identiﬁed these three
residues as deﬁning three critical points of contact with the
Figure 1. Cartoon of the synergistic actions of the Kef system in E. coli. The Kef system, which comprises both KefFC and KefGB (in E. coli), is a
ligand-gated K+ eﬄux system critical for the bacterial response to electrophilic insult. Glutathione (GSH) acts as an inhibitory ligand of Kef, holding
the channel closed. However, in the presence of electrophiles, GSH scavenges these species forming GS-X, which activates the Kef system resulting
in K+ eﬄux and concomitant H+ inﬂux. Consequently, activation of Kef results in a decrease in cellular pH, protonating nucleophiles and minimizing
their reactivity with electrophilic species. The GS-X conjugates subsequently undergo metabolism to less toxic species in enzyme-mediated
detoxiﬁcation reactions that also regenerate cytoplasmic GSH. Hence, Kef is part of a synergistic bacterial protection system, in which the
electrophiles are detoxiﬁed and, in parallel, their eﬀect is neutralized by modulation of the cellular pH.
Figure 2. Comparison of the GSH and nucleotide binding sites from EcKefC (A) and SdKef (B). (A) Mutagenesis studies have identiﬁed Q412
from EcKefFC as a key residue for GSH binding, and mutation to a larger residue (Q412K) results in loss of GSH binding.7 This observation is
supported by crystallographic data. (B) Q419 in SdKef is predicted to form interactions with GSH similar to those of Q412 in E. coli, and the Q419K
mutation also causes a loss of GSH binding, indicating that it plays a similar role in Kef from both species. A homology model of SdKefC, generated
on the basis of the GSH-bound EcKefC structure (Protein Data Bank entry 3L9W), supports these data. The ﬁgure was created using PyMOL.
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peptide backbone of GS-X.7,8 A structural transition that was
proposed to be associated with gating identiﬁed a critical role
for F441 (in E. coli), which caps the pocket in which GSH is
bound. This pocket is proposed to be unable to accommodate
the steric bulk of electrophiles that are conjugated to GSH such
that F441 is displaced, and this is believed to be the trigger for
activation of K+ eﬄux.7 Although the crystal structures provide
only a static snapshot of the protein,7 genetic data supported
this model for the role of F441 in both E. coli and Shewanella
Kef KTN domains.7
Initial studies indicated that inappropriate gating of Kef
might provide a mechanism for bacterial growth inhibition9,10
and thus provide an opportunity for the development of
antibacterial drugs with a novel target. A challenge that must be
met is the fact that Gram-negative bacteria possess very large
pools of GSH that could impede the binding of any potential
drug. In vivo studies led to the observation that the formation of
relatively low concentrations of ESG in the cytoplasm provided
strong activation of KefFC despite the presence of excess
GSH.4 However, to date, no direct quantitative analysis of the
binding of GS-X ligands to isolated Kef KTN domains has been
undertaken. Determination of the structural parameters
inﬂuencing the binding of GS(X) adducts to Kef is an
important step in understanding the gating mechanism and for
the development of assay systems for identifying novel
synthetic modulators of Kef activity. To address these aims,
we have developed a novel biophysical assay, which relies on
steady state ﬂuorescence spectroscopy, facilitated by a
ﬂuorescently labeled GSH-based probe containing the dansyl
chromophore, that allows both qualitative and quantitative
detection of binding to Kef. The probe exhibits solvatochromic
properties, in that both the wavelength and intensity of
emission are dictated by the nature of the probe’s environment.
This probe also exhibits attractive photophysical properties for
use in biological assays; excitation is achieved by irradiation at
340 nm, and an emission λmax of 573 nm is observed in free
solution. With the transition from a hydrophilic to a
hydrophobic environment, a dramatic shift in the λmax is
observed (530 nm). This system has been employed to evaluate
the aﬃnity for the Kef ligand binding domain displayed by a
range of natural and synthetic GS-X analogues. The results
correlate with data obtained using isothermal titration
calorimetry (ITC) and diﬀerential scanning ﬂuorimetry
(DSF). Consequently, we have demonstrated that the
ﬂuorescence-based assay is a useful tool for the development
of lead antibacterial compounds that target the Kef system.
■ EXPERIMENTAL PROCEDURES
Strains and Plasmids. The strains and plasmids used in
this study are described in Table S1 of the Supporting
Information. Expression construct pTrcSdKefH6 of the Kef
gene from Shewanella denitrif icans OS217 (accession number
NC007954.1) encodes 608 amino acids with an additional C-
terminal LEH6 tag. The synthetic clone was codon optimized
and cloned via an NcoI site at the 5′ end and a XhoI site on the
3′ end into a pTrc99A backbone by DNA 2.0 Ltd. Site-directed
mutants were produced using the Stratagene QuickChange
protocol. A soluble construct of the regulatory domain was
obtained by introduction of a second NcoI site into
pTrcSdKefH6 by site-directed mutagenesis at the 3′ end of
the membrane domain-encoding region followed by digestion
with NcoI and ligation. The construct, designated
SdKefQCTD, included the Q-linker starting at K391 and
fused at the 5′ end a further sequence encoding 10 amino acids
(GHELEVDIEP),9,10 corresponding to a putative regulatory
loop from the membrane domain. All constructs were
conﬁrmed by sequencing on both strands.
Potassium Eﬄux Measurements. Potassium eﬄux
experiments were performed as described previously.7
Potassium eﬄux was measured, using an ion selective
potassium electrode (ELIT 8031, Nico2000) and a lithium
acetate reference electrode (ELIT 003n) with a four-channel
ion analyzer (ELIT4), in 2 s intervals. Freshly transformed cells
[either E. coli MJF335 cells lacking KefB, KefC, and GshA or
MJF645 cells (lacking KefF and KefG in addition to KefB,
KefC, and GshA)] were cultured in K115 minimal medium,
containing 1 mM GSH, at 37 °C to an OD650 of ∼0.8−1.
11 The
cells were ﬁltered and washed with K10 buﬀer before being
suspended in 5 mL of potassium-free K0 buﬀer. The cells were
added to 30 mL of K0 medium in a stirred vessel held at 37 °C
with equilibrated electrodes inserted. After 5 min, the
electrophile was added to a ﬁnal concentration of 0.5 mM
[except for methylglyoxal (MG), which was added at a
concentration of 0.8 mM6]. Rate constants were obtained by
ﬁtting exponentials to the change in potassium concentration
after addition of the electrophile using Origin version 8.0
(Originlab).7
Protein Expression and Puriﬁcation. pTrcSdKefQCTD
was transformed for expression into E. coli strain MJF373,
which lacks the gene for the catabolite activator protein (CAP).
CAP is a common contaminant in immobilized metal ion
aﬃnity chromatography12 that could not be removed by size
exclusion when the Kef constructs were expressed in other
strains. The culture was grown at 37 °C in LB (500 mL,
containing 0.1% glucose) until an OD650 of 0.8 was reached.
After the sample had cooled to 30 °C, expression was induced
with IPTG (0.8 mM) for 4 h. Cells were harvested by
centrifugation and resuspended in 20 mL of phosphate-buﬀered
saline at pH 7.4 (8 g/L NaCl, 0.2 g/L KCl, 1.15 g/L Na2HPO4·
7H2O, and 0.2 g/L KH2PO4) containing an EDTA-free
protease cocktail (Sigma) and stored at −80 °C until use.
Cells were lysed with a French press (SLM Aminco) at a
pressure of 18000 lb/in.,2 and cell debris was removed by
centrifugation. The supernatant was incubated with 10 μg/mL
DNase (Sigma) at 4 °C for 30 min, ﬁltered (0.45 μm syringe
ﬁlters), and loaded onto a prewashed 1 mL column of Ni2+-
nitrilotriacetic acid agarose (Sigma). The column was washed
with 40 mL of buﬀer A containing 50 mM phosphate buﬀer
(pH 7.5), 150 mM NaCl, 10% glycerol, and 20 mM imidazole.
Bound protein was eluted with buﬀer B (equivalent to buﬀer A
but containing 300 mM imidazole). The peak fractions as
determined by UV−vis spectroscopy were subjected to buﬀer
exchange using a PD-10 column (GE Healthcare) and buﬀer C
containing 50 mM phosphate buﬀer (pH 7.5) and 150 mM
NaCl. The concentration of the resulting protein was calculated
using UV−vis spectroscopy and analyzed for purity using
Novex NuPAGE 4 to 12% Bis-Tris SDS−PAGE gels
(Invitrogen) with NuPAGE LDS sample buﬀer (Invitrogen).
Kef was further puriﬁed by size exclusion chromatography using
a 10/300 Superdex200 column (GE Healthcare) in buﬀer C for
ﬂuorescence and ITC experiments.
Fluorescence Measurements. Measurements were per-
formed in buﬀer C, using a 100 μL cuvette with 3 mm
excitation and emission path lengths (Hellma GmbH & Co.) at
20 °C and an Edinburgh Instruments FLS920 spectrometer.
Samples containing SdKefQCTD and DNGSH were excited at
Biochemistry Article
dx.doi.org/10.1021/bi5001118 | Biochemistry 2014, 53, 1982−19921984
340 nm, and emission spectra were measured from 395 to 670
nm. The steady state ﬂuorescence anisotropy was measured
with excitation at 340 nm and emission between 540 and 560
nm. Competition experiments were performed using samples
pretreated with excess DNGSH, at a 2× protein concentration,
and titrated with the ligand under study.
For qualitative competition measurements, a Perkin-Elmer
luminescence spectrometer was used with excitation at 340 nm
and emission spectra were recorded from 400 to 600 nm.
Samples containing 6 μM SdKefQCTD and 5 μM DNGSH
were prepared. A decrease in ﬂuorescence intensity after the
addition of the desired competing ligand, at a ﬁnal
concentration of 1 mM, was interpreted as an indication of
binding. The data are represented as ratios of the ﬂuorescence
intensities before and after the addition of the tested compound
at 525 nm.
Analysis of Ligand Binding by Fluorescence Spec-
troscopy. The data were ﬁt using a standard saturation
isotherm (see the Supporting Information for further
information). For DNGSH ﬂuorescence, λL was measured
directly and found to be 572.5 nm. Inverse titrations with high
SdKefQCTD concentrations allowed a good estimation of the
emission maximum for the bound form (λML) as 530 nm with a
quantum yield (Q) of 4. These three parameters were kept
ﬁxed during the ﬁtting while Kd and n were optimized. A
mutated protein bearing a Q419K mutation that abrogates
activation of Kef by GSH adducts7 was used to measure
background binding. The level of nonspeciﬁc binding was
observed to be very low, and thus, no routine corrections were
performed. For competition experiments, depletion of DNGSH
(L) as well as of the competing nonﬂuorescent ligand B was
taken into consideration during the analysis (see the
Supporting Information). Data were analyzed according to
Thrall et al.,13 using a Kd of 6 μM for DNGSH (derived in this
study). The dissociation constant for the competing ligand B,
KB, and n were optimized using Matlab2012a (Mathworks)
taking dilution of ligands and protein during the titration into
account. Equations are shown in the Supporting Information.
Diﬀerential Scanning Fluorimetry (DSF). Stock solutions
(100 and 10 mM) of the ligands under examination were
prepared in H2O. A protein master mix was prepared
containing SdKefQCTD (40 μM) and Sypro Orange (1:1000
dilution, Invitrogen) in buﬀer C. Ninety-six-well plates
(Axygen) were prepared using the protein master mix (22.5
μL, 12 μM protein) and ligand (2.5 μL, 1 mM ligand) (total
volume of 25 μL). Assays were performed using a Stratagene
Mx3005P qPCR machine with the integrated FAM/SYBR
Green I ﬁlter (excitation at 492 nm, emission at 516 nm). The
initial temperature was set to 25 °C, increasing in increments of
1 °C. The Tm was identiﬁed by ﬁtting to the Boltzmann
equation (Prism 5). The change in unfolding temperature
(ΔTm) was calculated as the change in Tm relative to the Tm of
the protein and dye in the absence of ligand. A Student’s t test
was performed to determine whether the changes were
statistically signiﬁcant.
Isothermal Titration Calorimetry (ITC). SdKefQCTD
samples were dialyzed overnight (molecular mass cutoﬀ of 14
kDa) against buﬀer C. Ligand stock solutions were prepared
using the same buﬀer. All solutions were degassed with a
ThermoVac instrument (MicroCal) before use, and measure-
ments were taken at 25 °C with a MicroCal iTC200 instrument
(GE Healthcare). The ligand solution was placed in the syringe
and the protein in the sample cell. The ligand was titrated into
the protein solution (20 injections, 1 × 0.4 and 19 × 2.0 μL).
The interval between injections was typically 180 s. In some
cases, the syringe was reﬁlled and the experiment was
continued until saturation was reached to allow assessment of
the baseline oﬀset. Control experiments were performed by
titrating the ligand solution into buﬀer. Data were analyzed
using Origin 7.0 (OriginLab Corp.) with a one-site model. All
binding experiments were repeated at least three times (see
Table 1).
Chemical Synthesis. All reagents were purchased from
Sigma-Aldrich or Alfa Aesar and were used without further
puriﬁcation. The UV light was provided by a Philips HB175
Facial Solarium (UVA, 365 nm, P = 4 × 15 W). Reverse phase
column chromatography was conducted on a Fluka Ltd. silica
gel 100 C18 reversed phase column. Analytical TLC analysis
was performed using Merck 60 RP-18 F254S aluminum-
supported thin layer chromatography sheets and visualized
using an ethanolic solution of ninhydrin. 1H and 13C nuclear
magnetic resonance (NMR) spectra were recorded on a Bruker
Avance 400 (400 and 100 MHz) or Bruker Avance III (500 and
125 MHz) spectrometer. Optical rotations were recorded at 20
°C at the sodium D line (589 nm).
DNGSH was synthesized from GSH and N-allyl-5-
(dimethylamino)naphthalene-1-sulfonamide via the photo-
chemical thiol-ene. Glutathione-S-conjugates were synthesized
from GSH and a range of electrophiles in H2O or a H2O/
methanol mixture and sodium hydroxide, via 1,4-addition.
Further details of synthesis and compound characterization are
provided in the Supporting Information.
Table 1. Aﬃnity of Ligands for SdKefQCTDa
electrophile GSH-S-conjugate Kd (μM) no. of sites (n) method no. of repeats
− DNGSH 6 ± 2 0.6 ± 0.2 emission peak 8
8 ± 2 1.1 ± 0.8 anisotropy 3
19 ± 6 0.7 ± 0.2 ITC 4
− GSH 900 ± 200 0.83 ± 0.04 emission peak 4
N-ethylmaleimide (NEM, 14) ESG 12 ± 3 0.7 ± 0.2 emission peak 3
23 ± 4 0.38 ± 0.05 ITC 3
methylglyoxal (MG) SLG 900 ± 200 0.71 ± 0.04 emission peak 4
N-tert-butylmaleimide (15) 5 0.4 ± 0.2 0.7 ± 0.2 emission peak 3
6.7 ± 0.27 0.41 ± 0.04 ITC 3
1-octen-3-one (22) 12 4.4 ± 0.5 0.81 ± 0.05 emission peak 3
aValues of the dissociation constant, Kd, and the determined number of sites per subunit, n, are shown for binding experiments with GSH and GSX
on a soluble fragment of Kef from S. denitrif icans measured by ﬂuorescence emission spectra, ﬂuorescence anisotropy, or ITC. In addition, the names
of the corresponding electrophiles are listed.
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■ RESULTS AND DISCUSSION
To gain insight into the binding of GS-X to the Kef carboxy-
terminal domain, we required a protein that was more
biochemically tractable than the KefFC system that we had
previously characterized from E. coli,7,8 which consists of two
proteins with only weak aﬃnity for each other. KefF is not
required for the activation or inhibition of KefC by ESG or
GSH, respectively, but poises the system to have higher
activity.14 The instability of the KefFC dimer of dimers in
extracts was previously found to interfere with biochemical
analysis.8 Thus, we sought to identify homologues that do not
require a KefF protein. After screening the NCBI organism
database, we identiﬁed several species that possessed a KefC-
like protein (Table S2 of the Supporting Information) but no
KefF (S. Ekkerman, C. Pliotas, S. Kinghorn, S. Miller, and T.
Rasmussen, unpublished observations). Heterologous expres-
sion of the Shewanella Kef homologue (hereafter termed
SdKef) in an E. coli strain lacking both KefFC and KefGB
resulted in a high rate constant for K+ eﬄux after addition of
the electrophile N-ethylmaleimide (NEM) (Figure 3). Muta-
tional analysis conﬁrmed that key residues identiﬁed from
genetic analysis of E. coli KefC (Figure 2) were also critical to
the activity of SdKef (Figure S1 of the Supporting
Information). To facilitate ligand binding studies on the
SdKef protein, a soluble construct of the cytosolic regulatory
domain was produced. To improve stability, the construct was
extended to include the Q-linker and the regulatory loop from
the membrane domain (residues H266−P274), which has been
shown previously to improve stability.8 We have previously
shown by static multiangle light scattering analysis that puriﬁed
Figure 3. Potassium eﬄux via Kef systems. (A) K+ eﬄux proﬁle for diﬀerent Kef systems. (B) Rate constants derived from the exponential ﬁtting of
the raw data. Eﬄux of potassium from E. coli strain MJF645, which lacks both the chromosomal Kef systems and glutathione biosynthesis,
transformed with plasmids expressing diﬀerent Kef systems. The eﬄux was triggered by NEM (arrow). Note that the electrode measures the amount
of K+ released from the cells (i.e., an increasing level of K+ in the medium indicates Kef activity). Eﬄux mediated by SdKef (red), EcKefFC (blue), or
EcKefC (green). The black line is the K+ release proﬁle observed with MJF645 cells alone treated with NEM (arrow). All cells were grown in the
presence of 1 mM GSH.
Figure 4. Synthesis of DNGSH (3) and eﬀect of the polarity of the solvent on the ﬂuorescence of DNGSH. (A) Reagents and conditions: (i) allyl
amine, DIPEA, CH2Cl2, 100%; (ii) GSH, DPAP, TCEP·HCl, THF/H2O, 40%. (B) Emission spectra of 45 μM DNGSH in diﬀerent mixtures of
distilled water with dioxane.
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SdKefQCTD exists in solution as 52.0 ± 2.5 kDa particles
corresponding to complexes of 2.0 ± 0.1 subunits (26.4 kDa
per monomer) (S. Ekkerman, C. Pliotas, S. Kinghorn, S. Miller,
and T. Rasmussen, unpublished observations), which is
consistent with the crystal structure for KTN domains.15−17
Design and Synthesis of the Fluorescent Probe
DNGSH (3). A robust biophysical method was required to
measure the binding of ligands to Kef. The development of a
solvatochromic ﬂuorescent probe allowed the use of
ﬂuorescence for both qualitative and quantitative detection of
binding of ligands to Kef. On the basis of our knowledge of
activators and inhibitors of Kef, a ﬂuorescent probe (3) with a
GSH core and the dansyl chromophore was designed (Figure
4A). The dansyl chromophore was chosen, as it is known to be
sensitive to the nature of its environment, and the biophysical
properties of dansyl-labeled amino acids have been extensively
studied.18,19 In addition, it is a relatively small ﬂuorophore and
is therefore less likely to completely disrupt ligand binding.
Because of the potential for S- to N-acyl transfer,20 synthesis
of an S-dansylated derivative of GSH required the installation of
a stable linker moiety. This aim was achieved via the reaction of
dansyl chloride (1) ﬁrst with allyl amine. The allylic double
bond then provided a synthetic handle for reaction with GSH
via the photochemical thiol-ene reaction. Optimization of the
reaction conditions, most signiﬁcantly through the addition of a
reducing agent, aﬀorded the desired probe DNGSH (3) in 40%
yield (Figure 4A).
When the ﬂuorescence spectrum of DNGSH (3) was
measured in a range of solutions with varying dioxane:water
ratios, the ﬂuorescence intensity increased with the proportion
of dioxane. In addition, as the amount of dioxane in the
solution increased, the λmax underwent a hypsochromic shift of
up to 45 nm. These observations indicate that changes in the
ﬂuorescence properties of DNGSH reﬂect changes in the
hydrophobicity of the environment experienced by the probe
(Figure 4B).
Binding of DNGSH to SdKefQCTD Detected by
Fluorescence Spectroscopy. Titration experiments, in
which DNGSH was incubated with increasing concentrations
of SdKefQCTD, were performed to conﬁrm the ability of
DNGSH to act as a solvatochromic ﬂuorescent probe for the
Kef system. When DNGSH bound to the protein, the
ﬂuorescence quantum yield increased and a substantial shift
in the λmax of the emission spectrum was observed (Figure 5A).
The λmax of the unbound probe (λL) was found, under our
experimental conditions, to be 572.5 ± 1.2 nm, and that of the
bound probe (λML) could be approximated at high
SdKefQCTD concentrations to be 530 nm. Under similar
conditions, the relative increase in the quantum yield upon
binding of DNGSH could also be estimated as Q = 4. This set
of experiments indicated that DNGSH was indeed binding to
Kef and that the probe was highly sensitive to the changes in
the nature of its environment in both the observed λmax and the
intensity of emission. Titration of DNGSH to SdKefQCTD
(Figure 5B) or the inverse (Figure 5C) provided binding
isotherms. In addition, the steady state ﬂuorescence anisotropy
was measured, which also changed upon binding because of the
decreased mobility of the ligand bound to the protein (Figure
Figure 5. Changes in ﬂuorescence when DNGSH binds to SdKefQCTD. (A) The emission spectrum of DNGSH is modiﬁed by the co-incubation
with SdKefQCTD, consistent with a hydrophobic environment for the dansyl group. (B) The emission peak position was measured upon titration of
DNGSH to 21 μM SdKefQCTD (○) or to buﬀer as a control (●). In addition, a titration of DNGSH to 7 μM of the SdKefQCTD Q419K mutant
is shown (⊕). (C) Change of the emission peak position or (D) ﬂuorescence anisotropy upon titration of SdKefQCTD to 5 μM DNGSH. Fitted
curves are shown as lines.
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5D). Binding experiments with the SdKefQCTD Q419K
mutant (Figure 5B), which has previously been shown to be
insensitive to activation by GS-X,7 indicated that this mutant is
unable to bind the GSH moiety of DNGSH. These data are
consistent with the crystal structure of the KefF−KefC−CTD
complex.7
Data were ﬁt to a single-site binding model, which accounted
for the change in quantum yield and depletion of free ligand
(see the Supporting Information for details). Good ﬁts were
obtained with this simple model, and no indications of
cooperative binding were seen. This is also reﬂected in the
Scatchard plot (Figure S2 of the Supporting Information) and a
Hill coeﬃcient (nH) of 1. The number of active binding sites, n,
in relation to the total protein concentration, [M]0, was lower
than estimated from the total protein concentration of
SdKefQCTD, which was optimized in the ﬁts along with the
dissociation constant, Kd. For titration of DNGSH to
SdKefQCTD a dissociation constant (Kd) of 6 ± 2 μM and a
number of active binding sites (n) of 0.6 ± 0.2 were obtained
on the basis of changes in λmax (see also Table 1). Anisotropy
experiments conﬁrmed these results with a Kd of 8 ± 2 μM and
an n of 1.1 ± 0.8. Binding of DNGSH by ITC (using ∼55 μM
protein; four repeats) resulted in a slightly higher dissociation
constant of 19 ± 6 μM (Figure 6). No signiﬁcant deviations
from a single-site model were seen in ITC experiments (Figure
6). However, as observed in the ﬂuorescence experiments, the
number of active sites was fewer than one per monomer (n =
0.7 ± 0.1). The apparent reduction in stoichiometry may be
due to partial unfolding of the protein.
Competition Experiments Using DNGSH as a Probe
for Ligand Binding.With conﬁrmation that DNGSH binds to
Kef, competition experiments were performed with the most
extensively studied Kef inhibitor (GSH), the strong activator
(ESG), and with the weak activator (SLG). The protein was
preincubated with a slight excess of DNGSH and titrated with
increasing concentrations of the competing ligand. On
displacement of DNGSH from the binding site, a decrease in
the ﬂuorescence intensity and a shift of the λmax back toward
the free probe in solution were observed (Figure 7A). Titration
curves showed that ESG had a higher aﬃnity for Kef than either
GSH or SLG (Figure 7B). Analysis of the data resulted in the
following values: Kd(ESG) = 12 ± 3 μM (n = 0.7 ± 0.2),
Kd(GSH) = 900 ± 200 μM (n = 0.83 ± 0.04), and Kd(SLG) =
900 ± 200 μM (n = 0.71 ± 0.04). The Kd values for GSH and
SLG could not be accurately determined as only a low degree
of saturation could be reached in the experiments. ITC
experiments (Figure 6) conﬁrmed the ﬂuorescence results for
ESG. A slightly higher dissociation constant [Kd(ESG)] of 23 ±
4 μM (n = 0.38 ± 0.05) was found in comparison to the
ﬂuorescence results. Only small signals were seen in the ITC
for titration with GSH and SLG, which could not be analyzed
as expected for a very low aﬃnity ligand (data not shown).
Regulatory ligands GSH, SLG, and ESG have been investigated
in detail physiologically.2,21,22 These new binding data can
readily be integrated into the physiological analysis, namely that
GSH is present at a concentration between 10 and 20 mM in
the cytoplasm, and thus, a low aﬃnity of Kef for this ligand can
be accommodated mechanistically. However, to achieve rapid
gating, one would predict a much higher aﬃnity for GS-X than
for GSH. MG is a poor activator and must accumulate to high
millimolar levels to activate KefGB,6 and the low aﬃnity,
comparable to that for GSH, ﬁts with the known facts regarding
MG activation, namely that strong activation by MG requires
both depletion of GSH and formation of a large pool of SLG.6
Requirements for Binding and Gating. To explore the
eﬀect of ligand structure on Kef binding and gating, a series of
ESG analogues were synthesized (Scheme 1; see the
Supporting Information for further details). The binding of
these ligands (4−12) was compared to that of GSH and ESG
using a qualitative version of the ﬂuorescence competition assay
(Figure 8A) and was independently validated using diﬀerential
scanning ﬂuorimetry (DSF) (Figure 8B).
The qualitative version of the ﬂuorescence assay employed
DNGSH in competition experiments, in which binding of a
Figure 6. ITC ligand binding experiments with SdKefQCTD. Titrations with DNGSH (left) and ESG (right) are shown with SdKefQCTD
concentrations of 55 and 60 μM, respectively. Residuals are shown for a single-site binding model. Representative curves from a single experiment
are shown.
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ligand results in displacement of DNGSH and a consequent
decrease in ﬂuorescence intensity. The binding of the ligand is
represented as a DNGSHbound:DNGSHligand ratio [FB:FL
(Figure 8A)], with a higher ratio indicating a greater aﬃnity
for Kef. In this assay, GSH and SLG have low FB:FL ratios,
consistent with weak binding to Kef, as expected from the data
described above. ESG and all of the ESG analogues show high
FB:FL ratios, consistent with an aﬃnity for Kef greater than
those of GSH and SLG, with N-tert-butylsuccinimido-S-
glutathione (5) showing the greatest Kef aﬃnity (Figure 8A).
Similar trends in Kef binding were observed using DSF. The
low aﬃnity of GSH and SLG for Kef results in a negligible
change in protein melting temperature between free and ligand-
bound states [ΔTm (Figure 8B)]. Compound 5 was observed
to show the greatest ΔTm, indicating tight binding to Kef. A
plot of ΔTm versus FB:FL (Figure 8C) reveals a good
correlation between the binding aﬃnity for Kef predicted by
the DNGSH-based ﬂuorescence competition assay and ΔTm
observed using DSF. Dissociation constants for compounds 5
and 12 were determined using the ﬂuorescence competition
assay. The GSH adduct of tert-butylmaleimide (5) has a Kd of
0.4 ± 0.2 μM (n = 0.7 ± 0.2) [Kd = 6.7 ± 0.3 μM by ITC (see
Figure S3 of the Supporting Information)] and of 1-octen-3-
one (12) a Kd of 4.4 ± 0.5 μM (n = 0.81 ± 0.05). These
compounds have binding aﬃnities for Kef that are signiﬁcantly
higher than that of GSH, suggesting that additional aﬃnity for
Kef results from the electrophile component of GS-X. This
aﬃnity might be as a result of hydrophobic interactions
between the conjugate and Kef. Alternatively, the increase in
aﬃnity might reﬂect an enthalpic increase in aﬃnity resulting
from a conformational change in the Kef protein and/or
entropic gains in aﬃnity resulting from the release of structured
water molecules that are lodged in the Kef protein prior to GS-
X binding.
Analysis of the structure binding relationships of the series of
ESG analogues (4−12) reveals that GSH adducts formed with
either rigid (4−9) or ﬂexible electrophiles result in compounds
that bind with similar aﬃnity to Kef (for example, compounds
6 and 12). However, these assays do not provide any
information about whether the adducts activate or inhibit Kef
activity. To determine whether ESG analogues 4−12 activated
Kef, an analysis of the electrophiles [13−22 (Figure 9B)]
corresponding to GS-X conjugates 4−7 and 10−12 was
conducted in a whole cell K+ eﬄux assay (see Experimental
Procedures). This analysis revealed that compounds containing
bulky and rigid ring substituents (5−7) showed similar
activation of eﬄux of K+ to ESG. Compound 8 possesses two
ketone groups, similar to the succinimide of compounds 4−7
but lacks the substituted nitrogen atom. Compound 9 possesses
Figure 7. Competition experiments. (A) Changes of emission spectra
with increasing concentrations of ESG at concentrations of 47 μM
SdKefQCTD and 112 μM DNGSH. (B) Changes in the emission peak
position with increasing concentrations of ESG (●), GSH (gray
circles), SLG (○), compound 5 (◇), and compound 12 (⊕). Fittings
are shown as lines.
Scheme 1. Synthesis of ESG Analogues 4−12a
aReagents and conditions: (i) enone, NaOH, H2O/MeOH, room temperature, 18−97%.
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only one ketone group and no substituted nitrogen atom. Both
of these compounds showed reduced binding aﬃnity for Kef
and little or no activation of K+ eﬄux, respectively. These
results suggest that rigid ligands that lack suﬃcient steric bulk
are not able to activate the Kef system. More ﬂexible
compounds 10−12 display aﬃnities for Kef similar to those
of the more rigid compounds (e.g., compounds 6 and 12) in
both the ﬂuorescence and DSF assays (Figure 8A,B). However,
Figure 8. Investigation of ESG and analogue Kef binding. (A) DNGSHbound:DNGSHligand ratios of ﬂuorescence (FB:FL), from a competition
experiment performed with 1 mM competing ligand (n = 3). (B) Changes in melting temperature in the presence of 1 mM ligand relative to that of
protein alone. (C) Investigation of the relationship of ﬂuorescence and thermal shift data. A plot of FB/FL vs ΔTm indicates a correlation between
the Kef ligand binding observed using each technique separately. (D) Structures of ESG and its analogues 4−12. Error bars represent the standard
deviation (n = 3). Signiﬁcance of changes evaluated by a Student’s t test (where ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05).
Figure 9. Dependence of SdKef activation on the structure of the GSX adduct formed with diﬀerent electrophiles. (A) Rate constants for K+ eﬄux as
a function of electrophile structure. Potassium eﬄux experiments were performed with E. coli strain MJF335 transformed with wild-type SdKef and
grown in the presence of GSH. All electrophiles were added to a ﬁnal concentration of 0.5 mM. (B) Structures of the electrophiles (13−22)
employed in the K+ eﬄux assay.
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the electrophiles corresponding to these compounds displayed
markedly diﬀerent abilities to evoke K+ eﬄux. Compound 16
caused signiﬁcant K+ release, whereas compound 22 was less
eﬀective at causing K+ release (Figure 9). The physical
parameter log P (P = octanol/water partition coeﬃcient)
(Figure S4 of the Supporting Information) gives an indication
of the lipophilicity of the compounds and thus the likelihood of
penetration into the cytoplasm, which is the site of the GSH
binding domain on SdKef. Compounds that are very lipophilic
may have very much lower concentrations in the cytosol
because of their partitioning into the lipid phase of the
membrane. Most of the electrophiles (15−22) exhibit
calculated log P (cLogP) values much higher than that of
NEM (14), which causes rapid loss of K+ via Kef after its
reaction with GSH20 and acts as a reference point for
permeation into the cytoplasm for the other electrophiles.
The data indicate that all of the electrophiles (13−22) should
make ready access to the GSH pool and react to form GS-X. As
all of the electrophiles react rapidly with GSH to form GS-X,23
this step is also unlikely to be rate-limiting for the overall
observed K+ eﬄux. Thus, failure of the electrophile to elicit K+
eﬄux represents a lack of Kef activation rather than a lack of
GS-X formation. It is interesting to note that N-cyclo-
hexylmaleimide (17) and 1-octen-3-one (22) have very similar
cLogP values (see the Supporting Information). However, N-
cyclohexylmaleimide (17) causes rapid K+ eﬄux, whereas
octenone (22) causes little K+ eﬄux. Therefore, these data
suggest that tight Kef binding alone is insuﬃcient for activation
of the Kef system, resulting in K+ eﬄux. Rather, the structural
nature of the electrophile also plays an important role in
determining whether the Kef system is activated, with a degree
of steric bulk and structural rigidity being mutual requirements
for eﬃcient Kef activation.
■ CONCLUSION
We have developed a simple, ﬂuorescence-based, system for
evaluating the binding of ligands to Kef. Using this system, in
association with other biophysical techniques, we have provided
the ﬁrst quantitative determination of the aﬃnity of GSH and
ESG for Kef (from S. denitrif icans). These data explain the
ability of ESG to displace GSH and activate Kef, despite the
presence of a vast excess of GSH in a cellular context. We
synthesized a collection of GSH derivatives and evaluated their
binding to Kef using the ﬂuorescence-based assay. We
determined tert-butylmaleimide (5) has a Kd of 0.4 ± 0.2
μM, as the highest-aﬃnity Kef ligand reported to date. Analysis
of the structure−activity data for these ligands revealed a
mutual requirement of steric bulk and structural rigidity to give
eﬀective activation of Kef. This information will be valuable in
the design of nonpeptide ligands for the Kef system that will aid
the validation of Kef as a potential therapeutic target.
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maleimide; MALS, multiangle light scattering; ITC, isothermal
titration calorimetry; DSF, diﬀerential scanning ﬂuorimetry.
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